Skip Navigation LinksHome > May 2014 - Volume 36 - Issue 4 > Dyskeratosis Congenita Complicated by Hepatic Fibrosis With...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000001
Clinical and Laboratory Observations

Dyskeratosis Congenita Complicated by Hepatic Fibrosis With Hepatic Vein Thrombosis

Yoshida, Hideki MD, PhD; Imamura, Toshihiko MD, PhD; Sakamoto, Kenichi MD; Asai, Daisuke MD; Nakatani, Takuya MD, PhD; Morimoto, Akira MD, PhD; Hosoi, Hajime MD, PhD

Supplemental Author Material
Collapse Box


We describe the case of 2 male siblings with dyskeratosis congenita (DC). Extensive genetic analysis failed to identify a causative genetic abnormality. The elder brother developed hepatic fibrosis accompanied with hepatic vein thrombosis at the age of 9 years. Recent studies have found that patients with DC sometimes develop hepatic complications, including cirrhosis. However, little is known about hepatic complications in patients with DC who lack these mutations. Further genetic studies are required to understand the relationship between DC and hepatic complications. In addition, although danazol can sometimes be effective for treating bone marrow failure, hepatotoxicity can be a major complication. Therefore, when danazol is administered to patients with DC, careful monitoring for hepatic complications is important.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.